Alessandro Scalia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alessandro Scalia has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Stephane Guy Carlier
Department of Cardiology, Research Institute for Health Sciences and Technology, University of Mons , Mons
5 shared publications - Anne Trelcat
Department of Cardiology, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), 7000 Mons, Belgium
4 shared publications - Fabrice Journe
Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, Research Institute for Health Sciences and Technology, University of Mons (UMONS), Avenue du Champ de Mars, 8, B7000 Mons, Belgium
4 shared publications - Nadège Kindt
Department of Clinical and Experimental Oncology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium
4 shared publications - Pierre Duez
Unit of Therapeutic Chemistry and Pharmacognosy, University of Mons, 7000 Mons, Belgium
2 shared publications - Rob Phillips
The Critical Care Research Group, Department of Medicine, The University of Queensland, Brisbane, Australia
2 shared publications
Latest Publications
- Open Access
- 31 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9487
In Vitro Modulation of Human Foam Cell Formation and Adhesion Molecules Expression by Ginger Extracts Points to Potential Cardiovascular Preventive Agents
Recent findings from the World Heart Federation (WHF) reported a significant increase in cardiovascular disease (CVD)-related deaths, highlighting the urgent need for effective prevention strategies. Atherosclerosis, a key precursor to CVD, involves the accumulation of low-density lipoprotein (LDL) and its oxidation within the endothelium, leading to inflammation and foam cell formation. Ginger extracts, known for their antioxidative and anti-inflammatory properties, show promise in preventing CVD initiation by inhibiting LDL oxidation and reducing foam cell formation. Our results revealed that the active fractions in ginger extracts had antioxidative effects, particularly fractions D and E. Further research is needed to identify the active compounds in these fractions and understand their mechanisms of action. In this context, microfluidic models could offer insights into the effects of ginger on monocyte recruitment in a more physiologically relevant context. Overall, ginger extracts represent a potential novel treatment for preventing CVD initiation, but additional studies are necessary to identify the active molecules in these fractions.
- 31 August 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9487
Open AccessIn Vitro Modulation of Human Foam Cell Formation and Adhesion Molecules Expression by Ginger Extracts Points to Potential Cardiovascular Preventive Agents
Recent findings from the World Heart Federation (WHF) reported a significant increase in cardiovascular disease (CVD)-related deaths, highlighting the urgent need for effective prevention strategies. Atherosclerosis, a key precursor to CVD, involves the accumulation of low-density lipoprotein (LDL) and its oxidation within the endothelium, leading to inflammation and foam cell formation. Ginger extracts, known for their antioxidative and anti-inflammatory properties, show promise in preventing CVD initiation by inhibiting LDL oxidation and reducing foam cell formation. Our results revealed that the active fractions in ginger extracts had antioxidative effects, particularly fractions D and E. Further research is needed to identify the active compounds in these fractions and understand their mechanisms of action. In this context, microfluidic models could offer insights into the effects of ginger on monocyte recruitment in a more physiologically relevant context. Overall, ginger extracts represent a potential novel treatment for preventing CVD initiation, but additional studies are necessary to identify the active molecules in these fractions.
- 22 December 2023
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 117 (1) , S25
Hyperhemic and non hyperhemic pressure ratio for the evaluation of coronary artery disease functional severity
- 22 December 2023
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 117 (1) , S25
Hyperhemic and non hyperhemic pressure ratio for the evaluation of coronary artery disease functional severity
- 15 August 2023
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 78 (9) , 1024-1032
Microcatheter-versus wire-based measurement of the fractional flow reserve
Background: Fractional flow reserve (FFR) guided-percutaneous interventions is nowadays the gold standard for optimal coronary artery revascularization. While multiple pressure guidewires have been validated, the use of microcatheter for FFR measurements is still a matter of debate. Objective: The aim of this study was to investigate the crossing profile characteristics of the NAVVUSV((R)) microcatheter as compared with the COMETTM pressure wire. At the same time, we compared non-hyperaemic pressure ratio (NHPR) and FFR measurements of both systems. Method/materials: In this retrospective study, all angiographically intermediate coronary artery stenoses each month were assessed, using either the NAVVUSV((R)) or the COMETTM pressure system, to receive coronary artery physiology assessment with NHPR and FFR measurements. The crossing profile of both systems was compared regarding objective coronary artery lesion characteristics using quantitative coronary analysis evaluation. Results: Over a period of 4.5 years, we evaluated 213 coronary artery stenoses using one of the two coronary tools. We found a 9.2% crossing profile failure rate using the microcatheter, compared to 0.7% in the pressure wire group (p<.001). The crossing failure was significantly correlated with the presence of coronary artery calcifications and angulation (p -.042, p -.049, respectively). FFR values were comparable be- tween the two groups and were significantly lower in the presence of coronary calcifications and proportional to the degree of stenosis (p -.036, p -.010). Pressure drift was comparable. Conclusion: Our observations are in line with other studies reporting the poor crossing profile of the NAVVUSV((R)) microcatheter. NHPR and FFR measures of both systems were well correlated.
- 15 August 2023
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 78 (9) , 1024-1032
Microcatheter-versus wire-based measurement of the fractional flow reserve
Background: Fractional flow reserve (FFR) guided-percutaneous interventions is nowadays the gold standard for optimal coronary artery revascularization. While multiple pressure guidewires have been validated, the use of microcatheter for FFR measurements is still a matter of debate. Objective: The aim of this study was to investigate the crossing profile characteristics of the NAVVUSV((R)) microcatheter as compared with the COMETTM pressure wire. At the same time, we compared non-hyperaemic pressure ratio (NHPR) and FFR measurements of both systems. Method/materials: In this retrospective study, all angiographically intermediate coronary artery stenoses each month were assessed, using either the NAVVUSV((R)) or the COMETTM pressure system, to receive coronary artery physiology assessment with NHPR and FFR measurements. The crossing profile of both systems was compared regarding objective coronary artery lesion characteristics using quantitative coronary analysis evaluation. Results: Over a period of 4.5 years, we evaluated 213 coronary artery stenoses using one of the two coronary tools. We found a 9.2% crossing profile failure rate using the microcatheter, compared to 0.7% in the pressure wire group (p<.001). The crossing failure was significantly correlated with the presence of coronary artery calcifications and angulation (p -.042, p -.049, respectively). FFR values were comparable be- tween the two groups and were significantly lower in the presence of coronary calcifications and proportional to the degree of stenosis (p -.036, p -.010). Pressure drift was comparable. Conclusion: Our observations are in line with other studies reporting the poor crossing profile of the NAVVUSV((R)) microcatheter. NHPR and FFR measures of both systems were well correlated.
- Open Access
The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers
Cardiovascular diseases are the leading causes of death worldwide, closely followed by cancer. To investigate the impact of breast cancer cell lines (SKBR3, MCF-7, and MDA-MB-231) on endothelial cell adhesion, a blended medium containing 30% breast-cancer-conditioned medium was prepared. This medium was then exposed to human umbilical vein endothelial cells (HUVECs) and monocytes (THP-1) for 48 h. Homemade oxidized low-density lipoproteins (oxLDL) were optionally added to the blended medium. Immunofluorescence was performed to assess the expression of E-selectin, connexin-43, and ICAM-1 on HUVECs, as well as LOX-1, CD36, and CD162 on THP-1. Additionally, unoxidized LDL was exposed to the three breast cancer cell lines for 48 h, and the formation of oxLDL was quantified. Our results revealed an upregulation of all six adhesion markers involved in the initiation of atherosclerosis when HUVECs and THP-1 were exposed to the breast-cancer-conditioned medium. Furthermore, this expression was further increased by exposure to oxLDL. We also observed a significant elevation in oxLDL levels when LDL was exposed to breast cancer cells. In conclusion, our findings successfully demonstrate an increased LDL oxidation in the presence of breast cancer cells, accompanied by an augmented expression of receptors involved in atherosclerosis initiation. These findings shed new light on the clinically observed interplay between atherosclerosis and cancer.
Open AccessThe Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers
Cardiovascular diseases are the leading causes of death worldwide, closely followed by cancer. To investigate the impact of breast cancer cell lines (SKBR3, MCF-7, and MDA-MB-231) on endothelial cell adhesion, a blended medium containing 30% breast-cancer-conditioned medium was prepared. This medium was then exposed to human umbilical vein endothelial cells (HUVECs) and monocytes (THP-1) for 48 h. Homemade oxidized low-density lipoproteins (oxLDL) were optionally added to the blended medium. Immunofluorescence was performed to assess the expression of E-selectin, connexin-43, and ICAM-1 on HUVECs, as well as LOX-1, CD36, and CD162 on THP-1. Additionally, unoxidized LDL was exposed to the three breast cancer cell lines for 48 h, and the formation of oxLDL was quantified. Our results revealed an upregulation of all six adhesion markers involved in the initiation of atherosclerosis when HUVECs and THP-1 were exposed to the breast-cancer-conditioned medium. Furthermore, this expression was further increased by exposure to oxLDL. We also observed a significant elevation in oxLDL levels when LDL was exposed to breast cancer cells. In conclusion, our findings successfully demonstrate an increased LDL oxidation in the presence of breast cancer cells, accompanied by an augmented expression of receptors involved in atherosclerosis initiation. These findings shed new light on the clinically observed interplay between atherosclerosis and cancer.
- Open Access
- 21 April 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1235
High Fidelity Pressure Wires Provide Accurate Validation of Non-Invasive Central Blood Pressure and Pulse Wave Velocity Measurements
Central blood pressure (cBP) is known to be a better predictor of the damage caused by hypertension in comparison with peripheral blood pressure. During cardiac catheterization, we measured cBP in the ascending aorta with a fluid-filled guiding catheter (FF) in 75 patients and with a high-fidelity micromanometer tipped wire (FFR) in 20 patients. The wire was withdrawn into the brachial artery and aorto-brachial pulse wave velocity (abPWV) was calculated from the length of the pullback and the time delay between the ascending aorta and the brachial artery pulse waves by gating to the R-wave of the ECG for both measurements. In 23 patients, a cuff was inflated around the calf and an aorta-tibial pulse wave velocity (atPWV) was calculated from the distance between the cuff around the leg and the axillary notch and the time delay between the ascending aorta and the tibial pulse waves. Brachial BP was measured non-invasively and cBP was estimated using a new suprasystolic oscillometric technology. The mean differences between invasively measured cBP by FFR and non-invasive estimation were −0.4 ± 5.7 mmHg and by FF 5.4 ± 9.4 mmHg in 52 patients. Diastolic and mean cBP were both overestimated by oscillometry, with mean differences of −8.9 ± 5.5 mmHg and −6.4 ± 5.1 mmHg compared with the FFR and −10.6 ± 6.3 mmHg and −5.9 ± 6.2 mmHg with the FF. Non-invasive systolic cBP compared accurately with the high-fidelity FFR measurements, demonstrating a low bias (≤5 mmHg) and high precision (SD ≤ 8 mmHg). These criteria were not met when using the FF measurements. Invasively derived average Ao-brachial abPWV was 7.0 ± 1.4 m/s and that of Ao-tibial atPWV was 9.1 ± 1.8 m/s. Non-invasively estimated PWV based on the reflected wave transit time did not correlate with abPWV or with atPWV. In conclusion, we demonstrate the advantages of a novel method of validation for non-invasive cBP monitoring devices using acknowledged gold standard FFR wire transducers and the possibility to easily measure PWV during coronary angiography with the impact of cardiovascular risk factors.
- 21 April 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1235
Open AccessHigh Fidelity Pressure Wires Provide Accurate Validation of Non-Invasive Central Blood Pressure and Pulse Wave Velocity Measurements
Central blood pressure (cBP) is known to be a better predictor of the damage caused by hypertension in comparison with peripheral blood pressure. During cardiac catheterization, we measured cBP in the ascending aorta with a fluid-filled guiding catheter (FF) in 75 patients and with a high-fidelity micromanometer tipped wire (FFR) in 20 patients. The wire was withdrawn into the brachial artery and aorto-brachial pulse wave velocity (abPWV) was calculated from the length of the pullback and the time delay between the ascending aorta and the brachial artery pulse waves by gating to the R-wave of the ECG for both measurements. In 23 patients, a cuff was inflated around the calf and an aorta-tibial pulse wave velocity (atPWV) was calculated from the distance between the cuff around the leg and the axillary notch and the time delay between the ascending aorta and the tibial pulse waves. Brachial BP was measured non-invasively and cBP was estimated using a new suprasystolic oscillometric technology. The mean differences between invasively measured cBP by FFR and non-invasive estimation were −0.4 ± 5.7 mmHg and by FF 5.4 ± 9.4 mmHg in 52 patients. Diastolic and mean cBP were both overestimated by oscillometry, with mean differences of −8.9 ± 5.5 mmHg and −6.4 ± 5.1 mmHg compared with the FFR and −10.6 ± 6.3 mmHg and −5.9 ± 6.2 mmHg with the FF. Non-invasive systolic cBP compared accurately with the high-fidelity FFR measurements, demonstrating a low bias (≤5 mmHg) and high precision (SD ≤ 8 mmHg). These criteria were not met when using the FF measurements. Invasively derived average Ao-brachial abPWV was 7.0 ± 1.4 m/s and that of Ao-tibial atPWV was 9.1 ± 1.8 m/s. Non-invasively estimated PWV based on the reflected wave transit time did not correlate with abPWV or with atPWV. In conclusion, we demonstrate the advantages of a novel method of validation for non-invasive cBP monitoring devices using acknowledged gold standard FFR wire transducers and the possibility to easily measure PWV during coronary angiography with the impact of cardiovascular risk factors.
- Open Access
- 1 January 2023
- Published by Fortune Journals in Anesthesia and Critical Care
- Vol. 05 (04) , 87-97
Global Hypertension Guidelines: Are Central Haemodynamics Critical and Neglected
Hypertension (HTN) is an elevated blood pressure (BP) compared to normative data and occurs in 30-50% of adults and is the number one risk of human death. While non-invasive brachial BP defines hypertension, physiologically BP is the product of the central haemodynamic (CH) variables of stroke volume (SV), heart rate (HR), cardiac output (CO) and systemic vascular resistance (SVR) or BP = (SV x HR) x SVR. Pathophysiologically HTN is the result of one or more elevated CH parameters and while global clinical guidelines recommend anti-hypertensive therapy to reduce CH BP monitoring is recommended to monitor therapeutic effectiveness. Significantly control of people diagnosed with HTN remains persistently dismal at <23% while CH are ignored. We reviewed Australian, Canadian, Chinese, European, Japanese, Singaporean, UK, US and International HTN guidelines. The focus of the guidelines on cardiovascular physiology, allied science and novel concepts of HTN management were assessed using proprietary word-count functions targeting BP and CH, and the results tabulated. A total of 695 pages and 478,537 words were published in the nine representative global HTN guidelines, with BP parameters mentioned 7,535 times (99.4%), and CH parameters mentioned 47 times (0.6%), while 4 of 9 (44%) guidelines omitted any mention of CH. All guidelines recommended BP definitions and BP-centric therapies, without mention of CH. The adoption of CH in HTN practice may improve our understanding of the aetiology of HTN and advance precision therapy in adults and children with this pandemic condition
- 1 January 2023
- Published by Fortune Journals in Anesthesia and Critical Care
- Vol. 05 (04) , 87-97
Open AccessGlobal Hypertension Guidelines: Are Central Haemodynamics Critical and Neglected
Hypertension (HTN) is an elevated blood pressure (BP) compared to normative data and occurs in 30-50% of adults and is the number one risk of human death. While non-invasive brachial BP defines hypertension, physiologically BP is the product of the central haemodynamic (CH) variables of stroke volume (SV), heart rate (HR), cardiac output (CO) and systemic vascular resistance (SVR) or BP = (SV x HR) x SVR. Pathophysiologically HTN is the result of one or more elevated CH parameters and while global clinical guidelines recommend anti-hypertensive therapy to reduce CH BP monitoring is recommended to monitor therapeutic effectiveness. Significantly control of people diagnosed with HTN remains persistently dismal at <23% while CH are ignored. We reviewed Australian, Canadian, Chinese, European, Japanese, Singaporean, UK, US and International HTN guidelines. The focus of the guidelines on cardiovascular physiology, allied science and novel concepts of HTN management were assessed using proprietary word-count functions targeting BP and CH, and the results tabulated. A total of 695 pages and 478,537 words were published in the nine representative global HTN guidelines, with BP parameters mentioned 7,535 times (99.4%), and CH parameters mentioned 47 times (0.6%), while 4 of 9 (44%) guidelines omitted any mention of CH. All guidelines recommended BP definitions and BP-centric therapies, without mention of CH. The adoption of CH in HTN practice may improve our understanding of the aetiology of HTN and advance precision therapy in adults and children with this pandemic condition
- Open Access
- 6 December 2022
- Published by Springer Nature in Research Square
Global Hypertension Guidelines; Are Central Haemodynamics Critical and Neglected?
Background: Hypertension (HTN) is an elevated blood pressure (BP) compared to normative data. However, physiologically it is a product of the central haemodynamic variables of stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR) (BP = (SV x HR) x SVR). Multiple global clinical guidelines recommend anti-hypertensive therapy to reduce BP, yet effective BP control of people diagnosed with HTN remains persistently dismal at ~25% while central haemodynamics are ignored. BP is a cornerstone of HTN practice, yet is an insensitive measure of circulation and sheds little light on the critical therapeutic central haemodynamic variables of SV, CO and SVR, and ultimately may limit our understanding of the pathophysiology of HTN and its management. Methods: Word searches were conducted on Australian, Canadian, Chinese, European, Japanese, Singaporean, UK, US and International hypertension guidelines using the Adobe or Microsoft word count function, with specific searches made for BP, and central haemodynamic parameters, and the results tabulated. Results: A total of 695 pages and 478,537 words were published in nine HTN guidelines by representative global organisations, with BP parameters mentioned 7,535 times, and central haemodynamic parameters mentioned 47 times. All guidelines recommended BP target values and pressure-led therapies, while no central haemodynamic targets were noted. Conclusions: Although physiologically core to the aetiology and treatment of HTN, central haemodyanmic parameters are ignored in current practice guidelines. Poor global outcomes suggest the inclusion of central haemodynamics in everyday practice may improve our understanding of HTN and facilitate the delivery of precise anti-hypertensive therapy.
- 6 December 2022
- Published by Springer Nature in Research Square
Open AccessGlobal Hypertension Guidelines; Are Central Haemodynamics Critical and Neglected?
Background: Hypertension (HTN) is an elevated blood pressure (BP) compared to normative data. However, physiologically it is a product of the central haemodynamic variables of stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR) (BP = (SV x HR) x SVR). Multiple global clinical guidelines recommend anti-hypertensive therapy to reduce BP, yet effective BP control of people diagnosed with HTN remains persistently dismal at ~25% while central haemodynamics are ignored. BP is a cornerstone of HTN practice, yet is an insensitive measure of circulation and sheds little light on the critical therapeutic central haemodynamic variables of SV, CO and SVR, and ultimately may limit our understanding of the pathophysiology of HTN and its management. Methods: Word searches were conducted on Australian, Canadian, Chinese, European, Japanese, Singaporean, UK, US and International hypertension guidelines using the Adobe or Microsoft word count function, with specific searches made for BP, and central haemodynamic parameters, and the results tabulated. Results: A total of 695 pages and 478,537 words were published in nine HTN guidelines by representative global organisations, with BP parameters mentioned 7,535 times, and central haemodynamic parameters mentioned 47 times. All guidelines recommended BP target values and pressure-led therapies, while no central haemodynamic targets were noted. Conclusions: Although physiologically core to the aetiology and treatment of HTN, central haemodyanmic parameters are ignored in current practice guidelines. Poor global outcomes suggest the inclusion of central haemodynamics in everyday practice may improve our understanding of HTN and facilitate the delivery of precise anti-hypertensive therapy.
- Open Access
- 19 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12552
Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells
Cardiovascular diseases (CVD) and cancers are the two main causes of death worldwide. The initiation and progression of atherosclerosis is, in large part, caused by oxidized low-density lipoproteins (oxLDL); interestingly, oxLDL may also play a role in cancer cell metabolism and migration. As oxLDL are generally obtained by tedious ultracentrifugation procedures, “home-made” oxLDL were obtained by (i) applying a purification kit to isolate LDL and VLDL from human plasma; (ii) isolating LDL from VLDL by gel permeation chromatography (GPC); and (iii) oxidating LDL through CuSO4 incubation. On three HPV-positive head and neck cancer cells (HNCC) (93VU-147T, UM-SCC47, and UPCI-SCC154), cell migration was assessed using Boyden chambers, the Wnt/ß-catenin pathway was analyzed by Western Blotting, and the expression of two oxLDL receptors, LOX-1 and CD36, in response to oxLDL exposure, was analysed by immunofluorescence. Our data indicate: (a) a non-significant difference between reference and “home-made” oxLDL; (b) a decreased migration, parallel to an inhibition of the ß-catenin pathway; and (c) an increase of CD36 and LOX-1 expression in all HNCC. In conclusion, we successfully produced oxLDL. Our results demonstrate a decrease in HNCC migration after oxLDL exposure, and an increased expression of LOX-1 and CD36 associated with lipid uptake.
- 19 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12552
Open AccessDevelopment of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells
Cardiovascular diseases (CVD) and cancers are the two main causes of death worldwide. The initiation and progression of atherosclerosis is, in large part, caused by oxidized low-density lipoproteins (oxLDL); interestingly, oxLDL may also play a role in cancer cell metabolism and migration. As oxLDL are generally obtained by tedious ultracentrifugation procedures, “home-made” oxLDL were obtained by (i) applying a purification kit to isolate LDL and VLDL from human plasma; (ii) isolating LDL from VLDL by gel permeation chromatography (GPC); and (iii) oxidating LDL through CuSO4 incubation. On three HPV-positive head and neck cancer cells (HNCC) (93VU-147T, UM-SCC47, and UPCI-SCC154), cell migration was assessed using Boyden chambers, the Wnt/ß-catenin pathway was analyzed by Western Blotting, and the expression of two oxLDL receptors, LOX-1 and CD36, in response to oxLDL exposure, was analysed by immunofluorescence. Our data indicate: (a) a non-significant difference between reference and “home-made” oxLDL; (b) a decreased migration, parallel to an inhibition of the ß-catenin pathway; and (c) an increase of CD36 and LOX-1 expression in all HNCC. In conclusion, we successfully produced oxLDL. Our results demonstrate a decrease in HNCC migration after oxLDL exposure, and an increased expression of LOX-1 and CD36 associated with lipid uptake.
- 8 July 2022
- Published by Open Source Publications in Journal of Clinical Images and Medical Case Reports
- Vol. 3 (7)
An unusual culprit lesion in acute coronary syndrome: In stent-restenosis of a subclavian artery stent
A 73-year old man with past medical history of coronary artery bypass grafting in 2012 and subclavian artery stenting in 2021 was scheduled for an ophthalmologic minor surgery requiring conscious sedation. During the surgery, he developed hemodynamic instability and shortness of breath requiring the conversion to general anesthesia with mechanical ventilation. An electrocardiogram was immediately realized revealing deep negative T waves in all the precordial leads. Elevated troponin level confirmed the diagnosis of non-ST elevation myocardial infarction. Urgent coronary artery angiography revealed a known left coronary system with a chronic Left Anterior Descending (LAD) artery occlusion, a chronic occlusion of the distal circumflex artery and a severe stenosis of left main stem. The right coronary artery presented a significant and calcified stenosis on its mid part. The two venous grafts on the obtuse marginal and the posterolateral artery were both patent. The left subclavian artery could not be crossed to selectively film the left internal mammary artery and an angiogram revealed a tight stenosis in the previous stented segment, limiting the blood flow in the left internal mammary artery. Careful review of the in-stent restenosis suggested neointimal hyperplasia and stent fracture, as detected by stentboost imaging.
- 8 July 2022
- Published by Open Source Publications in Journal of Clinical Images and Medical Case Reports
- Vol. 3 (7)
An unusual culprit lesion in acute coronary syndrome: In stent-restenosis of a subclavian artery stent
A 73-year old man with past medical history of coronary artery bypass grafting in 2012 and subclavian artery stenting in 2021 was scheduled for an ophthalmologic minor surgery requiring conscious sedation. During the surgery, he developed hemodynamic instability and shortness of breath requiring the conversion to general anesthesia with mechanical ventilation. An electrocardiogram was immediately realized revealing deep negative T waves in all the precordial leads. Elevated troponin level confirmed the diagnosis of non-ST elevation myocardial infarction. Urgent coronary artery angiography revealed a known left coronary system with a chronic Left Anterior Descending (LAD) artery occlusion, a chronic occlusion of the distal circumflex artery and a severe stenosis of left main stem. The right coronary artery presented a significant and calcified stenosis on its mid part. The two venous grafts on the obtuse marginal and the posterolateral artery were both patent. The left subclavian artery could not be crossed to selectively film the left internal mammary artery and an angiogram revealed a tight stenosis in the previous stented segment, limiting the blood flow in the left internal mammary artery. Careful review of the in-stent restenosis suggested neointimal hyperplasia and stent fracture, as detected by stentboost imaging.
- Open Access
- 5 May 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (5) , 513
Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas
Cardiovascular disease (CVD) and cancer are two major causes of death worldwide. The question is, “Could there be a link between these two pathologies in addition to their shared, common risk factors?” To find some answers, we studied the effect of oxidized low-density lipoproteins (oxLDL) on head and neck cancer (HNC) cell lines, since oxLDL is a major contributor to atherosclerosis and the principal cause of CVD. In this study, we exposed three HNC cell lines (Detroit 562, UPCI-SCC-131 and FaDu) to oxLDL. We investigated two oxLDL receptors, CD36 and Lox-1, using immunofluorescence. Cancer cell migration was evaluated using Boyden chambers and the Wnt/β-catenin pathway was investigated using Western blotting. We demonstrated that the expression of CD36 and Lox-1 significantly increases after exposure to oxLDL. Moreover, we found that oxLDL reduces the migration of HNC cell lines, an observation that is in line with an increased degradation of β-catenin under oxLDL. Finally, the inhibition of CD36 with sulfosuccinimidyl oleate (SSO) reverses the inhibition of cell migration. In conclusion, we report that oxLDL seems to induce an increase in CD36 expression on HNC cell lines, enhancing the uptake of these lipids in cells to finally decrease cancer cell migration via the CD36/β-catenin pathway.
- 5 May 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (5) , 513
Open AccessEffect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas
Cardiovascular disease (CVD) and cancer are two major causes of death worldwide. The question is, “Could there be a link between these two pathologies in addition to their shared, common risk factors?” To find some answers, we studied the effect of oxidized low-density lipoproteins (oxLDL) on head and neck cancer (HNC) cell lines, since oxLDL is a major contributor to atherosclerosis and the principal cause of CVD. In this study, we exposed three HNC cell lines (Detroit 562, UPCI-SCC-131 and FaDu) to oxLDL. We investigated two oxLDL receptors, CD36 and Lox-1, using immunofluorescence. Cancer cell migration was evaluated using Boyden chambers and the Wnt/β-catenin pathway was investigated using Western blotting. We demonstrated that the expression of CD36 and Lox-1 significantly increases after exposure to oxLDL. Moreover, we found that oxLDL reduces the migration of HNC cell lines, an observation that is in line with an increased degradation of β-catenin under oxLDL. Finally, the inhibition of CD36 with sulfosuccinimidyl oleate (SSO) reverses the inhibition of cell migration. In conclusion, we report that oxLDL seems to induce an increase in CD36 expression on HNC cell lines, enhancing the uptake of these lipids in cells to finally decrease cancer cell migration via the CD36/β-catenin pathway.